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Background: Persistent high-risk human papillomavirus (HR-HPV) infection has been implicated in the development
of high-grade cervical intraepithelial neoplasia (CIN) and cervical cancer. Invariant natural killer T (iNKT) cells produce
large amounts of cytokines to regulate immune responses. However, the role of iNKT cells in human persistent
HPV-infected cervical tissues is unknown.
Methods: In our study, 201 patients with diagnoses ranging from normal ectocervical tissue to CINIII from June
2010 to May 2012 were enrolled. HPV DNA and HPV types were detected using the hybrid capture-2 HPV DNA test.
Flow cytometry was used to investigate iNKT and CD3+ T cell infiltration into cervical tissues. Real-time quantitative
reverse transcription-polymerase chain reaction was used to study IFN-γ expression and immunohistochemistry was
used to determine CD3+ T cell distribution.
Results: A significant increase in iNKT cells was observed in HPV-positive cervical tissues (p < 0.05), especially in
CINII-III (p < 0.01). IFN-γ expression was also increased in HPV-positive cervical tissues (p < 0.05). CD3+ T cells were
detected among both epithelium and stromal layers in cervical tissues, and the percentage of CD3+ T cells in
HPV-positive cervical tissues was similar to that in HPV-negative cervical tissues (p > 0.05).
Conclusions: The iNKT cell aggregation in cervical tissues during the progression from HPV infection to CIN
indicates that iNKT cells might play an important role in suppressing immunity. IFN-γ expression could also be
related to the HPV infection status. Preventing the accumulation or functioning of iNKT cells in cervical tissues
may be a viable method to prevent the development of CIN.
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Cervical cancer is the third most common cancer world-
wide in females, with approximately 529,800 new cases
each year, nearly 85% of which occur in developing coun-
tries [1]. Infection with human papillomavirus (HPV) is a
major cause of cervical cancer. After infection with HPV,
precursor lesions precede the development of cervical can-
cer; these lesions are referred to as cervical intraepithelial
neoplasia (CIN) grades I, II and III and are characterized by
a series of histological abnormalities [2]. Low-grade lesions
(CINI) usually clear spontaneously. However, high-grade
CIN (CINII/III) lesions often persist and may progress to
carcinoma [3]. Persistent infection with high-risk (HR)
HPV has been implicated in the development of CIN II/III
and invasive cervical cancer [4,5]. Infection also triggers a
series of immune responses during lesion progression.
Invariant natural killer T (iNKT) cells are a sub-
population of T cells characterized by the expression of a
restricted αβ T-cell receptor (TCR) repertoire: Vα24-JαQ
paired with Vβ11 in humans. iNKT cells also co-express
natural killer (NK) cell receptors such as NK1.1 [6]. Distinct
from conventional T cells, iNKT cells specifically recognize
a glycolipid antigen α-galactosylceramide (αGalCer) pre-
sented by the non-classical class I-like MHC molecule
CD1d. CD1d-recruited iNKT cells rapidly produce large
amounts of Th1 and Th2 cytokines, including gamma
interferon (IFN-γ), interleukin-4 (IL-4), IL-10 and IL-13,
which protect against viral infections and cancers [7,8].
iNKT cells also suppress self-reactive immune responses,
preventing autoimmunity [9,10] and contributing to trans-
plant tolerance induction [11,12].
Several recent studies have demonstrated the pivotal
anti-tumor effects of iNKT cells and have reported
reduced numbers of iNKT cells in patients with malig-
nant diseases, including colon cancer, head and neck
cancer, breast cancer, renal cell cancer and melanoma
[13]. In a mouse model [14], iNKT cells were attracted
to a grafted HPV16-E7-expressing epithelial hyperplasia
instead of HPV-negative tissues and expressed IFN-γ.
iNKT cells, the major source of IFN-γ, had the paradoxical
capacity to locally suppress immune effector mechanisms
after specifically being attracted to persistent HR-HPV-
infected lesions.
Thus far, nothing is known about the specific role of
iNKT cells in regulating local cervical immunity in
humans. In this study, we asked whether iNKT cells play
a role in persistent human HPV-infected cervical tissues.
We demonstrated that in the progression from HPV
infection to CIN, iNKT cell accumulation might play
an important role in suppressing immunity. Further, IFN-γ
expression could also be related to HPV infection status.
Preventing the accumulation or functioning of iNKT cells
in cervical tissues may be a viable way to prevent the
development of CIN.Methods
Patients
All clinical specimens were obtained from the outpatient
department of gynecology in West China Second Univer-
sity Hospital, Sichuan University. Written informed consent
was obtained from all patients. Patients with abnormal Pap
tests who needed to be diagnosed by biopsy using a colpo-
scope were eligible for this study. All patients were older
than 25 years old; patients included in this study had not
received any prior cervical treatment within 12 months
from study enrollment and did not suffer from other infec-
tions (such as herpes simplex virus [HSV] or chlamydia);
malignancies and gravidas were excluded. This study was
approved by the Medical Ethics Committee of West China
Second University Hospital, Sichuan University (approval
number 2009-044).
Detection of HPV DNA in cervical specimens
HPV DNA specimens were collected with cervical brushes
(Digene, Gaithersburg, Maryland, USA) prior to the appli-
cation of acetic acid and iodine using a colposcope. HPV
DNA was analyzed using the Digene Hybrid Capture® 2
High-Risk HPV DNA Test kit (Qiagen, Gaithersburg,
Maryland, USA) according to the manufacturer’s instruc-
tions. Thirteen HR-HPV types were detected, including
types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68.
Five hundred microliters of denaturation reagent was
added to the specimen transport medium, and the sam-
ple was placed in a 65°C water bath for 45 minutes.
Then, 75 μl of the mixture and 25 μl of the high-risk
HPV probe were transferred to a hybridization micro-
plate, vortexed for 3 minutes, and incubated in a 65°C
water bath for 30 minutes. The entire contents were
pipetted into a capture microwell and vortexed for 60 mi-
nutes at room temperature (RT). After discarding the
liquid from the wells, 75 μl of detection reagent 1 was
added to the wells for 30 minutes at RT and discarded
again. After washing the capture wells with wash buffer
6 times, 75 μl of detection reagent 2 was added to the
wells for 15 minutes in the dark. The negative high-risk
calibrator and the quality control reagent were tested
simultaneously. Finally, the results were analyzed using
the Digene assay analysis software DML 2000. Signal
strengths with relative light units (RLU)/cutoff (CO)
ratios ≥1.0 were considered positive.
Biopsy samples
The biopsy samples were obtained under a colposcope
according to a standard protocol that included conven-
tional visual assessment, the application of 5% acetic
acid and iodine, the recognition of the transformation
zone and the identification of the abnormal area. In each
patient, one biopsy was taken from a suspected CIN
lesion of the cervix, and another biopsy was taken from
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from the most typical and severe parts of the lesions
under a colposcope to avoid the possibility of different
grades presented in the same specimen to the greatest
extent. Each biopsy sample was divided into 2 parts for
histopathological diagnosis in the pathology department
and for laboratory research. The histopathological diag-
nosis was reviewed by two senior experts from pathology
department in our hospital. The biopsy samples for flow
cytometry were transported in media at 4°C and ana-
lyzed within two hours. The biopsy samples for real-
time quantitative reverse transcription-polymerase chain
reaction (RT-PCR) were immediately frozen in liquid
nitrogen. The biopsy samples for immunohistochemistry
(IHC) were immersed in 10% formalin for 24 hours and
embedded in paraffin.
Regents and flow cytometry
Anti-human monoclonal antibodies (Ab) to CD3 (Clone
UCHT1), TCR Vα24 (Clone Cl5), TCR Vβ11 (Clone C21),
IgG1 (Clone 679.1Mc7) and IgG2a (Clone 7 T4-1 F5) were
purchased from Beckman Coulter (Fullerton, California,
USA). The FcR Blocking Reagent was purchased from
Miltenyi Biotec (Friedrich-Ebert-Straße, Bergisch Gladbach,
Germany). The Live/Dead Near-IR Fixable Dead Cell
staining kit was purchased from Invitrogen (Eugene,
Oregon, USA).
The cervical tissue was cut into the smallest pieces
possible in ice-cold media at 4°C. The tissue suspension
was transferred to a 70-μm cell strainer. After centrifu-
ging the cell suspensions at 30 g for 3 minutes to
remove cell aggregates and debris, the supernatant was
then centrifuged at 400 g for 5 minutes at 4°C. The cervical
tissue cells were used for flow cytometry by discarding the
supernatant. The resuspended cells were divided into 2
tubes with an optimal volume of 100 μl for 5×105 - 1×106
cells and were stained with anti-CD3, anti-TCR Vα24 and
anti-TCR Vβ11 antibodies or anti-CD3, IgG1 and IgG2a as
isotype controls for 30 minutes at 4°C in the dark. Prior to
the antibody staining of cells, FcR block and viability stains
were added to each tube for 30 minutes on ice in the dark.
Negative controls and single-color compensation controls
were prepared simultaneously. Stained cells were analyzed
on a FACSCalibur flow cytometer (BD Biosciences; San
Jose, California, USA).
Real-time quantitative RT-PCR
The cervical tissue was ground as finely as possible in
liquid nitrogen using a pestle. Total RNA was extracted
using TRIzol reagent according to the manufacturer’s in-
structions (Invitrogen). To avoid contamination with gen-
omic DNA, cDNA was synthesized from total RNA using
the PrimeScript® RT reagent Kit with gDNA Eraser (TaKaRa
Biotechnology, Dalian, China) and was stored at -80°C.Real-time quantitative PCR reactions were performed
in a total volume of 50 μl in the presence of 5 μl of
cDNA, 300 nM of forward and reverse PCR primers and
25 μl of iQ SYBR Green Supermix (BIO-RAD). Each
cDNA sample was analyzed in duplicate using an ABI
Prism 7300 Sequence Detector (Applied Biosystems)
under the following conditions: an initial step of 3 minutes
at 95°C; 40 cycles of 15 seconds at 95°C, 15 seconds at 55°C
and 30 seconds at 60°C; and a final melting-curve step of
15 seconds at 95°C, 30 seconds at 60°C and 15 seconds at
95°C to prevent nonspecific fluorescence derived from
unintentional products such as primer-dimers. SYBR
Green real-time PCR primers for IFN-γ, CD3 and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
were as follows: IFN-γ [15], forward 5′-GAA TTG
GAA AGA GGA GAG TGA CAG A-3′, reverse 5′-
GTC TCC ACA CTC TTT TGG ATG CT-3′; CD3
[16], forward 5′-TCG CCA GTC GAG AGC TTC A-
3′, reverse 5′-GGG CTG GTA GAG CTG GTC ATT-
3′; and GAPDH [17], forward 5′-CCA CCC ATG GCA
AAT TCC-3′, reverse 5′-GAT GGG ATT TCC ATT
GAT GAC A-3′. After the reactions, standard curves
and cycle threshold (Ct) values were determined. All
Ct values were normalized to the housekeeping gene
GAPDH to adjust for unequal amounts of RNA.
Immunohistochemistry
The formalin-fixed, paraffin-embedded cervical tissue
blocks were sectioned at 4-μm thickness and mounted
onto SuperFrost/Plus glass slides. The slides were depar-
affinized and rehydrated and then incubated in a 3%
H2O2 solution in methanol at RT for 10 minutes to
block endogenous peroxidase activity. The sections were
incubated with 10 mM citrate buffer (pH 6.0) at 95°C
for 10 minutes to unmask the antigen epitopes and with
normal goat serum (NGS) in phosphate-buffered saline
(PBS) at RT for 1 hour to prevent non-specific antibody
binding. The primary antibody, mouse monoclonal anti-
human CD3 (Clone PS1, ZSGB-BIO), was applied at a
1:50 dilution to sections and incubated in a humidified
chamber at 4°C overnight. For primary antibody detec-
tion, specific goat polyclonal antibodies were used at a
dilution of 1:200 for 30 minutes at RT. After washing in
PBS, streptavidin-horseradish peroxidase (Sav-HRP) con-
jugates were applied to the sections in the dark at RT for
30 minutes, followed by a diaminobenzidine (DAB) sub-
strate solution to reveal the color of the antibody stain-
ing. For negative controls, sections were stained with
PBS instead of the primary Ab. Normal human normal
lymph nodes were used as a positive control. All slides
were counterstained with hematoxylin. Positive cell
numbers were analyzed by microscopic counting (400×)
from 10 randomly selected areas.
Table 2 Patient classification
HPV-positive group HPV-negative group
FCM RT-PCR IHC FCM RT-PCR IHC
NCT 13 12 10 9 8 10
cervicitis 7 8 6 7 7 7
CIN I 6 7 7 8 5 6
CIN II 8 9 8 0 0 0
CIN III 14 6 13 0 0 0
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The statistical analysis was performed using the SPSS
software, version 13.0. Results groups are shown as the
means ± standard deviations (SDs). Comparisons be-
tween groups were performed using two-tailed Student’s
t tests and analysis of variance with Levene’s test. If the
distribution was extremely skewed, a nonparametric
two-tailed Mann-Whitney U test was used. Comparisons
among multiple groups were performed with one-way
analysis of variance (ANOVA) followed by Fisher’s
protected least significant difference (PLSD) post hoc
test. When the P value was <0.05, differences were
considered significant.Results
Patient characteristics
From June 2010 to May 2012, a total of 201 patients
were enrolled in the study. According to the pathological
examinations, the biopsies of all of the cervical tissues
were diagnosed as normal ectocervical tissue (NCT),
chronic cervicitis, CINI, CINII or CINIII. In the study,
134 patients were classified as HPV-positive (66.7%) by
HC-2, 67 of whom were diagnosed with high-grade CIN
by a pathologist. In the HPV-negative group, none of the
subjects were diagnosed with high-grade CIN. The
patient characteristics are summarized in Table 1.
There were 72 patients included in the flow cytometry
test, 62 patients in the RT-PCR test and 67 patients in
the IHC test. The patient classification for each test is
presented in Table 2.Distribution of CD3+ T cells in cervical tissues
We quantified the percentages of CD3+ T cells in the
live cell gate (viability stain-negative) in cervical tissues
by flow cytometry from an HPV-positive group (n = 48)
and an HPV-negative group (n = 24). The proportion of
CD3+ T cells in the HPV-positive group was similar to
that in the HPV-negative group (mean, 0.8845% vs.
0.8483%, p = 0.775) (Figure 1A, B). We then compared
the CD3+ T cell percentage in CINIII samples (n = 14)
with all of the other samples (n = 58) and found that
CD3+ T cell numbers were significantly increased in
CINIII cervical tissues (mean, 1.1343% vs. 0.7943%,
p = 0.045) (Figure 1C, D), which is similar to a previ-
ous study by Carrero et al. [18].Table 1 Patient characteristics
HPV-positive group HPV-negative group
Total number entered 134 67
Median age (range) 38.2 ± 7.9 36.9 ± 8.7
Pathological results,
(NCT/cervicitis/CINI/II/III)
35/21/20/25/33 27/21/19/0/0To confirm the distribution of CD3+ T cells in cervical
tissues, we immunostained HPV-positive (n = 44) and
HPV-negative cervical tissue (n = 23) for CD3. Immuno-
reactivity with an anti-CD3 Ab was noted in both
epithelium and stromal layers from formalin-fixed,
paraffin-embedded cervical tissue sections. There were
no significant differences in CD3 expression between
HPV-positive and HPV-negative tissues (mean, 0.900%
vs. 0.868%, p = 0.528) (Figure 2A, B). Similar to the flow
cytometry results, CD3 expression was significantly
increased in CINIII samples (n = 13) compared to all
of the other samples (n = 54) (mean, 1.108% vs.
0.820%, p = 0.001) (Figure 2C, D).
Infiltration of iNKT cells in cervical tissues
There were no significant differences in CD3+ T cells
between the HPV-positive and HPV-negative groups,
and iNKT cells are a population of CD3+ T cells. There-
fore, to measure the number of iNKT cells in cervical
tissues, we used the ratio of Vα24+/Vβ11+ cells to
CD3+ T cells as the percentage of iNKT cells. An in-
creased proportion of iNKT cells was observed in the
HPV-positive group (n = 48) compared to the HPV-
negative group (n = 24) (mean, 0.6062% vs. 0.2789%, p =
0.017) (Figure 3A, B). Because there is overwhelming evi-
dence that persistent infection with HR-HPV causes high-
grade CIN [3,4], we divided the HPV-positive group into 2
groups: a < CINII subgroup, with NCT to low-grade CIN
(n = 26), and a ≥ CINII subgroup with high-grade CIN
(n = 22). A significantly higher proportion of iNKT
cells were detected in the ≥ CINII subgroup compared
to the < CINII subgroup (mean, 0.8077% vs. 0.3845%,
p = 0.001) (Figure 3C, D). The proportion of iNKT cells
in the < CINII subgroup was similar to that in the HPV-
negative group (mean, 0.3845% vs. 0.2789%, p = 0.466)
(Figure 3E, F).
IFN-γ expression in cervical tissues
INKT cells play a crucial role in the immune response
by expressing IFN-γ [19,20]. Whether IFN-γ plays an
anti- or a pro-tumor role in human cervical tissues has
not been demonstrated. We detected IFN-γ expression
to confirm its function and the relationship between
iNKT cells and IFN-γ in human cervical tissues. Because
Figure 1 The percentage of CD3+ T cells in live cells of human cervical tissues in the HPV-positive group is similar to that in the HPV-negative
group, but significantly increased in CINIII cervical tissues. A, Flow cytometry plots of CD3+ T cells in live cells of HPV-positive and HPV-negative
groups, as detected by CD3-APC staining; B, The bar graph shows CD3+ T cells as percentages of live cells isolated from HPV-positive and
HPV-negative cervical tissues (p = 0.775). C, Flow cytometry plots of CD3+ T cells in live cells of CINIII and all other < CINIII cervical tissues, as
detected by CD3-APC staining; D, The bar graph shows CD3+ T cells as percentages of live cells isolated from CINIII and all other < CINIII
cervical tissues (*p = 0.045).
Hu et al. Diagnostic Pathology  (2015) 10:20 Page 5 of 10the percentages of CD3+ T cells were similar in the
HPV-positive and HPV-negative groups, the amount of
IFN-γ in cervical samples was measured using the 2ΔCt
method, which uses the ratio of the 2-Ct of IFN-γ to the
2-Ct of CD3 in real-time quantitative RT-PCR to prevent
interference from other cell types, such as fibroblasts.
Increased IFN-γ expression was observed in the HPV-
positive group (n = 42) compared to the HPV-negative
group (n = 20) (mean, 0.0987 vs. 0.0339, p = 0.026)
(Figure 4A). Furthermore, IFN-γ expression in the
high-grade CIN subgroup (n = 15) was increased signifi-
cantly compared to the HPV-negative group (n = 24)
(mean, 0.1081 vs. 0.0339, p = 0.027) but was similar to
expression in the NCT to low-grade CIN subgroup (n = 27)
(mean, 0.1081 vs. 0.0903, p = 0.534). IFN-γ expression in
the NCT to low-grade CIN subgroup was similar to
expression in the HPV-negative group (mean, 0.0903 vs.
0.0339, p = 0.078) (Figure 4B).
Discussion
In this study, we demonstrated that iNKT cells are
accumulated in persistently HR-HPV-infected cervical
tissues, especially in CINII-III. We further verified that
IFN-γ expression was also increased in these HR-HPV-infected cervical tissues, but only in high-grade CIN.
There were no significant differences between the
HPV-positive and HPV-negative cervical tissues in the
distribution of CD3+ T cells. This study is the first to
suggest that iNKT cells function to suppress immunity
in human persistent HR-HPV-infected high-grade CIN
tissues. IFN-γ expression may also be related to HPV
infection status.
HPV is the most common sexually transmitted infec-
tion worldwide. However, approximately 80% of young
women clear HPV infections within 12-18 months
[21,22]. Indeed, persistent HR-HPVs, especially HPV
types 16/18, are crucial for the progression of high-grade
CIN to invasive carcinoma [4,5]. In our study, the total
prevalence of HR-HPV infection was 66.7% (134/201),
which is consistent with the rate of 75.2% from a recent
study of 575 women with abnormal cervical smears at a
coloscopy clinic [23]. Moreover, HR-HPV was detected
in all 58 women diagnosed as CINII/III. In the HPV-
negative group, no CINs were detected, which is consist-
ent with the hypothesis that almost all high-grade lesions
are caused by persistent HR-HPV infection [24].
Although HPV infection initiates more than 99% of cer-
vical cancers, only 0.7% of HPV infections will eventually
Figure 2 The distribution of CD3+ T cells in HPV-positive cervical tissues is similar to that in HPV-negative cervical tissues, but significantly
increased in CINIII cervical tissues. A, a1 and a2, IHC of CD3+ T cells in HPV-positive cervical tissues detected by CD3 staining (IHC 10× and
100×); b1 and b2, IHC of CD3+ T cells in HPV-negative cervical tissues detected by CD3 staining (IHC × 10 and × 100). B, The bar graph shows
CD3+ T cells as percentages of cervical tissues isolated from the HPV-positive and HPV-negative groups (p = 0.528). C, a1 and a2, IHC of CD3+ T
cells in CINIII cervical tissues detected by CD3 staining (IHC 10× and 100×); b1 and b2, IHC of CD3+ T cells in all other < CINIII cervical tissues
detected by CD3 staining (IHC 10× and 100×). D, The bar graph shows CD3+ T cells as percentages of cervical tissues isolated from CINIII and all
other < CINIII cervical tissues (*p = 0.001).
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may not be sufficient for the development of cervical
cancer, the majority of the risk of progression to cancer
from HR-HPV infection remains unexplained.
The local immune response seems to play an import-
ant role in the evolution of CIN. CD3+ T cells were
closely correlated with recurrence in patients who
underwent conization because of CINIII, which may be
due to the failure of the immune response in more
severe lesions [26]. In our study, CD3+ T cell numbers
were increased in both the epithelium and stromal layers
of CINIII cervical tissues, supporting others’ findings
that CD3+ T cells may play a causal role in the develop-
ment of CIN [18]. However, in this study, the distribu-
tion and proportion of CD3+ T cells in the HPV-positive
group were similar to those in the HPV-negative group,
suggesting that HPV infection status was not due to the
changes in the infiltration of local CD3+ T cells in cer-
vical tissues. Moreover, in local immunity, it has been
reported that the activation of both CD4+ and CD8+ T
cells is not altered during the course of HPV infection
[14]. These data suggest that although CD3+ T-cell infil-
tration plays a crucial role in the progression of high-
grade CIN, the progression of HPV infection in cervical
tissues is not due to changes in CD3+ (including CD4+
and CD8+) T cells.NKT cells are thought to play a promoting or regula-
tory role in a wide range of disease conditions [7,8] and
are associated with the modulation of NK cells, macro-
phages and dendritic cells [27,28]. NKT cells also play a
role as effector cells, with cytolytic functions against
tumor cells [29]. Despite the importance of iNKT cells,
little knowledge exists concerning the role of iNKT cells
in local immunity. Intratumoral iNKT cell numbers are
increased significantly in colorectal carcinomas [30]. In
contrast, as in other advanced malignancies [19,20], defi-
ciencies in the number of iNKT cells have been observed
in the peripheral blood [31]. It is thought that iNKT cells
may migrate from the peripheral blood into tumors.
Although we also detected increased numbers of iNKT
cells in HPV-positive cervical tissues, another study
demonstrated that circulating iNKT cell numbers were
not reduced in patients with HPV infections or CINIII
patients compared to patients with CINI/II or normal
individuals [32]. These data suggest that circulating
iNKT cells may be ineffective in the course of HPV
infection and the progression of cervical neoplasia,
which does not support the anti-tumor hypothesis of
migration.
The accumulation of iNKT cells may play a role in
suppressing the local immune environment of the cervix.
The immunosuppressive role of iNKT cells has been
Figure 3 The proportion of iNKT cells in total CD3+ T cells in HPV-positive cervical tissues is significantly increased, especially increased in ≥
CINII subgroup; and the proportion of iNKT cells to CD3+ T cells in ≥ CINII subgroup is significantly in the HPV-positive group, but in < CINII
cervical tissues of the HPV-positive group is similar to that in the HPV-negative group. A, Flow cytometry plots of iNKT cells in CD3+ T cells in
HPV-positive and HPV-negative cervical tissues, as detected by Vα24 and Vβ11 staining; B, The bar graph shows iNKT cells as percentages of CD3
+ T cells isolated from HPV-positive and HPV-negative cervical tissues (*p = 0.017). C, Flow cytometry plots of iNKT cells in CD3+ T cells in the
HPV-positive cervical tissues of≥ CINII and < CINII subgroups, as detected by Vα24 and Vβ11 staining; D, The bar graph shows iNKT cells as
percentages of CD3+ T cells isolated from HPV-positive cervical tissues of ≥ CINII and < CINII subgroups (*p = 0.001). E, Flow cytometry plots of
iNKT cells in CD3+ T cells from the ≥ CINII subgroup of HPV-positive cervical tissues and HPV-negative cervical tissues, as detected by Vα24 and
Vβ11 staining; F, The bar graph shows iNKT cells as percentages of CD3+ T cells isolated from ≥ CINII subgroup of HPV-positive cervical tissues
and HPV-negative cervical tissues (p = 0.046).
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deficient mice with hematopoietic tumors survive longer
than wild-type (WT) mice [35]. The same study also
showed that donor skin grafts were rejected in iNKT
knockout (KO) mice, while the grafts were tolerated in
WT mice [12]. During the course from initial HPV in-
fection to the development of histological abnormalities
in the cervix, persistent infection is a crucial precondi-
tion. In our study, iNKT cells increased in CINII/IIIlesions, supporting the idea that these high-grade pre-
malignancies have a vital relationship with persistent
HR-HPV infection. We hypothesized that the accumula-
tion of iNKT cells induces a local immunosuppressive
environment that helps HR-HPV infection to escape
from elimination and results in high-grade CIN. Moreover,
the number of iNKT cells in the < CINII HPV-positive
group was similar to that in the control group, which fits
with data demonstrating that low-grade lesions usually
Figure 4 IFN-γ expression in cervical tissues. A, The bar graph shows RT-PCR results of IFN-γ expression in HPV-positive and HPV-negative cervical
tissues. IFN-γ expression is significantly increased in HPV-positive cervical tissues (*p= 0.026). B, The bar graph shows IFN-γ expression in ≥ CINII subgroup
of HPV-positive cervical tissues, <CINII subgroup of HPV-positive cervical tissues and HPV-negative cervical tissues. IFN-γ expression is significantly increased
in the ≥ CINII subgroup of HPV-positive cervical tissues (*p= 0.027), expression in the ≥ CINII subgroup of HPV-positive cervical tissues is similar to that in
the < CINII subgroup (p= 0.534) and expression in the < CINII subgroup of HPV-positive cervical tissues is comparable to that in the HPV-positive cervical
tissues (p= 0.078).
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reversible and may be eliminated by the host immune
system without inducing further lesions [36].
Another type of NKT cells, noninvariant NKT cells
(type II NKT cells), are considered a suppressive factor
in tumor immunosurveillance [37,38]. We did not detect
type II NKT cells in our study, but they are not thought
to play a role in the local immune response to HPV
infection [14].
Furthermore, we sought to investigate how iNKT cells
function in cervical tissues. INKT cells produce IFN-γ in
several diseases [19,20]. In this study, we found that the
amount of IFN-γ increased significantly in HPV-positive
cervical tissues, corresponding with iNKT cell accumula-
tion. In general, IFN-γ is a pro-inflammatory cytokine in
advanced cancers that promotes anti-tumor immunosur-
veillance [19,31,39]. In contrast, IFN-γ acts as an anti-
inflammatory factor in some autoimmune diseases [40].
A recent murine model indicated that iNKT cells induce
a local immune-suppressive environment with IFN-γ
production [14], supporting the hypothesis that although
low levels of IFN-γ are proinflammatory, once a certain
threshold is reached, the anti-inflammatory action of
IFN-γ dominates and converts the local epithelial envir-
onment into an immune-suppressive setting [41]. Our
data indicated that iNKT cells and IFN-γ both exhibit
the same increasing trend in HPV-positive cervical
tissues. Therefore, we concluded that the accumulation
of iNKT cells and the increased production of IFN-γ
suppress the persistent HR-HPV-infected cervical envir-
onment and induce high-grade CIN.
In addition, IFN-γ expression in < CINII cervical
tissues of the HPV-positive group was higher than that
in controls but only slightly lower than that in CINII/IIIcervical tissues, with no statistical significance. We
hypothesize that in the early stages of HR-HPV infection,
other factors that produce IFN-γ may have little function in
CIN progression during persistent HR-HPV infection.
However, our study did not confirm a direct relationship
between iNKT cell accumulation and IFN-γ expression. To
clarify this point, future experiments are needed.
NK cells, as large granular lymphocytes, play an im-
portant role in the early stages of immune responses. In
addition to cytotoxicity, NK cells function by producing
cytokines, especially of IFN-γ [42]. One previous study
confirmed that although increased numbers of NK cells
were detected in CIN compared to NCT and cervical
carcinoma (CxCa), no IFN-γ production by NK cells was
detectable in NCT and CIN, except for CxCa [43]. Further-
more, our observations do not exclude the additional
involvement of tumor necrosis factor (TNF)-α, IL-17, etc.
However, although TNF-α has anti-inflammatory effects,
IFN-γ plays a central regulatory role in immune responses
[41]; in cutaneous immunity, the secretion of IFN-γ, but
not IL-17, played a crucial role [44].
It is possible that different grades of CIN may be present
in the different parts of biopsy specimens. In our study,
each biopsy sample was divided into two parts for histo-
pathological diagnosis in the pathology department and for
laboratory research. As a result, the possibility of grouping
bias is inevitable, as the flow cytometry and real-time quan-
titative RT-PCR destroyed the morphology of the speci-
mens. However, we found that the immunohistochemistry
results were consistent with the histopathological grading
from the pathology department. Therefore we believe that
the grouping bias was at an acceptable level.
In conclusion, the results of this investigation indicate
that iNKT cells are capable of suppressing the local
Hu et al. Diagnostic Pathology  (2015) 10:20 Page 9 of 10immune environment in persistent HR-HPV-infected
cervical tissues by producing IFN-γ to induce high-grade
CIN. Therefore, blocking iNKT cell accumulation may
be useful for either treating persistent HPV infections or
preventing the progression from CIN to cervical cancer.
Further studies are required to confirm our findings.
Conclusions
iNKT cell accumulation in cervical tissues during the
progression from HPV infection to CIN indicates that
iNKT cells may play an important role in suppressing
immunity. IFN-γ expression may also be related to the
HPV infection status. Preventing the accumulation or
functioning of iNKT cells in cervical tissues may be a
viable method to prevent the development of CIN.
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